Evidence map›Paper›PMID 40931213›Full record

ArticleNature metabolism2025

In vivo itaconate tracing reveals degradation pathway and turnover kinetics.

Hanna F Willenbockel, Alexander T Williams, Alfredo Lucas, Mack B Reynolds, Emeline Joulia, Maureen L Ruchhoeft, Birte Dowerg, Pedro Cabrales, Christian M Metallo, Thekla Cordes

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Microparticles synthesized from itaconate polyesters enable metabolite delivery and elicit immunoregulatory outcomes.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  2. Article
  3. A Role for Astrocyte Metabolism in Species-Specific Neuronal Development.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Role of itaconate in intestinal disease (Review).International journal of molecular medicine · 2026
    Review
  6. Review
  7. Itaconate modifications: Mechanisms and applications.Journal of intensive medicine · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Hanna F WillenbockelDepartment of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany.
Alexander T WilliamsDepartment of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Alfredo LucasDepartment of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Mack B ReynoldsMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Emeline JouliaMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3278-4412
Maureen L RuchhoeftMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Birte DowergDepartment of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany.
Pedro CabralesDepartment of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Christian M MetalloMolecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA. metallo@salk.edu.ORCID http://orcid.org/0000-0003-2404-3040
Thekla CordesDepartment of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany. thekla.cordes@tu-braunschweig.de.ORCID http://orcid.org/0000-0002-8097-191X

Funding

Bioengineering a Dual Function Protein Construct to Detoxify Heme and HemoglobinR01HL159862 · NHLBI · OHIO STATE UNIVERSITY · PI BUEHLER, PAUL WERNER, CABRALES, PEDRO · 2021 to 2024
$2.6M
Non-essential amino acids and sphingolipid diversity in cancer progressionR01CA234245 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI METALLO, CHRISTIAN MICHAEL · 2019 to 2023
$1.9M
NCI NIH HHS R01 CA234245NHLBI NIH HHS R01 HL159862United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP) HT9425-23-1-0388U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA234245
6 · The paper itself

Abstract

Itaconate is an immunomodulatory metabolite that alters mitochondrial metabolism and immune cell function. This organic acid is endogenously synthesized by tricarboxylic acid (TCA) metabolism downstream of TLR signalling. Itaconate-based treatment strategies are under investigation to mitigate numerous inflammatory conditions. However, little is known about the turnover rate of itaconate in circulation, the kinetics of its degradation and the broader consequences on metabolism. By combining mass spectrometry and in vivo

Indexed as

SuccinatesAcetyl Coenzyme AAnimalsCitric Acid CycleKidneyKineticsLiverMaleMiceMice, Inbred C57BLRatsSuccinic AcidAcetyl Coenzyme Aitaconic acidSuccinatesSuccinic Acid

Identifiers

PMID40931213
PMCPMC12460153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.